Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
Viscoli C, Herbrecht R, Akan H, Baila L, Sonet A, Gallamini A, Giagounidis A, Marchetti O, Martino R, Meert L, Paesmans M, Ameye L, Shivaprakash M, Ullmann AJ, Maertens J; Infectious Disease Group of the EORTC. Viscoli C, et al. Among authors: shivaprakash m. J Antimicrob Chemother. 2009 Dec;64(6):1274-81. doi: 10.1093/jac/dkp355. Epub 2009 Oct 19. J Antimicrob Chemother. 2009. PMID: 19841031 Clinical Trial.
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, Schwartz S, Ullmann AJ, Meert L, Paesmans M, Marchetti O, Akan H, Ameye L, Shivaprakash M, Viscoli C. Herbrecht R, et al. Among authors: shivaprakash m. Bone Marrow Transplant. 2010 Jul;45(7):1227-33. doi: 10.1038/bmt.2009.334. Epub 2010 Jan 11. Bone Marrow Transplant. 2010. PMID: 20062093 Clinical Trial.
Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.
Winkler M, Pratschke J, Schulz U, Zheng S, Zhang M, Li W, Lu M, Sgarabotto D, Sganga G, Kaskel P, Chandwani S, Ma L, Petrovic J, Shivaprakash M. Winkler M, et al. Among authors: shivaprakash m. Transpl Infect Dis. 2010 Jun;12(3):230-7. doi: 10.1111/j.1399-3062.2009.00490.x. Epub 2010 Jan 11. Transpl Infect Dis. 2010. PMID: 20070619 Free PMC article.
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.
Condra JH, Holder DJ, Schleif WA, Blahy OM, Danovich RM, Gabryelski LJ, Graham DJ, Laird D, Quintero JC, Rhodes A, Robbins HL, Roth E, Shivaprakash M, Yang T, Chodakewitz JA, Deutsch PJ, Leavitt RY, Massari FE, Mellors JW, Squires KE, Steigbigel RT, Teppler H, Emini EA. Condra JH, et al. Among authors: shivaprakash m. J Virol. 1996 Dec;70(12):8270-6. doi: 10.1128/JVI.70.12.8270-8276.1996. J Virol. 1996. PMID: 8970946 Free PMC article.
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.
Dinubile MJ, Friedland I, Chan CY, Motyl MR, Giezek H, Shivaprakash M, Weinstein RA, Quinn JP. Dinubile MJ, et al. Among authors: shivaprakash m. Eur J Clin Microbiol Infect Dis. 2005 Jul;24(7):443-9. doi: 10.1007/s10096-005-1356-0. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15990986 Clinical Trial.
74 results